Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device

Primary Objective: The primary objective of this pilot study is to gain voluntary feedback from patients with neurological diseases and their caregivers regarding their experiences using the MemorEM head device. This information may help in new designs of the MemorEM and suggest ways to increase compliance for future clinical trials and eventual commercialization. Secondary Objective: The secondary objective is to note areas of potential improvement in the progression of the subject's neurological disease and identify the potential for the MemorEM to treat neurological diseases other than Alzheimer's disease. The investigators are also interested in Alzheimer's variants like those with ApoE4 alleles (none of the participants in the 8-person pilot were Apo-E4 positive), known mutations causing early onset Alzheimer's, and Posterior Cortical Atrophy.

NCT Number	NCT07222605
Lead Sponsor	eQ8Health Corporation d/b/a CareONE Concierge Collaborators: NeuroEM Therapeutics, Inc.
Conditions	Alzheimer Disease, Parkinson Disease, Frontotemporal Dementia, Cortico Basal Degeneration, Posterior Cortical Atrophy (PCA), Neurological Diseases or Conditions, Dementia
Enrollment	1,000 participants
Start Date	2025-12-01
Primary Completion	2027-12-15 (estimated)
Study Completion	2029-12-15 (estimated)
Updated on ClinicalTrials.gov	2026-02-05